Search Results - "Åkerlund, M."

Refine Results
  1. 1

    Ultrasound image analysis using deep neural networks for discriminating between benign and malignant ovarian tumors: comparison with expert subjective assessment by Christiansen, F., Epstein, E. L., Smedberg, E., Åkerlund, M., Smith, K., Epstein, E.

    Published in Ultrasound in obstetrics & gynecology (01-01-2021)
    “…Objectives To develop and test the performance of computerized ultrasound image analysis using deep neural networks (DNNs) in discriminating between benign and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Improved screening of fall risk using free-living based accelerometer data by Kelly, D., Condell, J., Gillespie, J., Munoz Esquivel, K., Barton, J., Tedesco, S., Nordstrom, A., Åkerlund Larsson, M., Alamäki, A.

    Published in Journal of biomedical informatics (01-07-2022)
    “…[Display omitted] •Gait features, extracted from accelerometers worn in community based free living conditions, can predict falls with moderate sensitivity and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Women with fair phenotypes seem to confer a survival advantage in a low UV milieu. A nested matched case control study by Lindqvist, Pelle G, Epstein, Elisabeth, Landin-Olsson, Mona, Åkerlund, Måns, Olsson, Håkan

    Published in PloS one (2020)
    “…Sun exposure in combination with skin pigmentation is the main determinant for vitamin D status. Human skin color seems to be adapted and optimized for…”
    Get full text
    Journal Article
  8. 8

    Effect of SR49059, an orally active V 1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea by Brouard, R., Bossmar, T., Fournié‐Lloret, D., Chassard, D., Åkerlund, M.

    “…Objective To investigate the clinical effect of SR49059 when given shortly before the onset of menstruation as a preventative treatment of dysmenorrhoea…”
    Get full text
    Journal Article
  9. 9

    ONO‐8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women by Steinwall, M., Åkerlund, M., Bossmar, T., Nishii, M., Wright, M.

    “…Objective  To determine the effect of ONO‐8815Ly on uterine contractions. Design  A randomised, double‐blind, placebo‐controlled, dose‐ascending, cross‐over…”
    Get full text
    Journal Article
  10. 10

    Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: Effects of the oxytocin antagonist atosiban by Bossmar, Thomas, Åkerlund, Mats, Fantoni, Guido, Szamatowicz, Jazec, Melin, Per, Maggi, Mario

    “…Objective: Our purpose was to study myometrial oxytocin and type V1 vasopressin receptors, the in vitro contractile effects of these hormones, and the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Synthetic antagonists of the myometrial response to vasopressin and oxytocin by Melin, P, Trojnar, J, Johansson, B, Vilhardt, H, Akerlund, M

    Published in Journal of endocrinology (01-10-1986)
    “…With the aim of developing inhibitors of vasopressin- and oxytocin-induced uterine activity, 17 analogues of 1-deamino-oxytocin were synthesized by the…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women by Bossmar, T, Forsling, M, Akerlund, M

    “…The posterior pituitary hormones appear to be involved in the etiology of primary dysmenorrhoea, but mechanisms regulating their release, particularly the…”
    Get more information
    Journal Article
  15. 15

    The relationship between cadmium and lead burdens and preterm labor by Fagher, U, Laudanski, T, Schütz, A, Sipowicz, M, Akerlund, M

    “…To study the possible involvement of lead and cadmium in mechanisms of preterm labor. Estimations of lead and cadmium in blood, myometrium and placenta of…”
    Get more information
    Journal Article
  16. 16

    Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea by Brouard, R., Bossmar, T., Fournié‐Lloret, D., Chassard, D., Åkerlund, M.

    “…Objective To investigate the clinical effect of SR49059 when given shortly before the onset of menstruation as a preventative treatment of dysmenorrhoea…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Variations in plasma concentrations of vasopressin during the menstrual cycle by Forsling, M L, Akerlund, M, Strömberg, P

    Published in Journal of endocrinology (01-05-1981)
    “…Plasma vasopressin concentrations, determined by radioimmunoassay, were followed throughout the menstrual cycle in eight healthy women. The concentrations were…”
    Get more information
    Journal Article
  19. 19

    Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists by Ekström, P, Juchnicka, E, Laudanski, T, Akerlund, M

    Published in Contraception (Stoneham) (01-07-1989)
    “…Mechanisms for the therapeutic effect of oral contraceptives in dysmenorrhea were studied by recording intrauterine pressure on the first day of menstrual…”
    Get more information
    Journal Article
  20. 20

    Influence of high lead and cadmium soil content on human reproductive outcome by Laudanski, T, Sipowicz, M, Modzelewski, P, Bolinski, J, Szamatowicz, J, Razniewska, G, Akerlund, M

    “…The influence of lead and cadmium on human reproductive outcome was studied in areas of Eastern Poland with high specific soil contamination with these heavy…”
    Get more information
    Journal Article